Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House of Representatives Committee on Financial Services, Subcommittee on Capital Markets, Securities, and Investment. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee.
{iframe}https://www.businesswire.com/news/home/20180523006308/en/Biotech-Leader-Testifies-House-Capital-Markets-Subcommittee{/iframe}